Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.
Identifieur interne : 003749 ( Main/Exploration ); précédent : 003748; suivant : 003750Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.
Auteurs : Yae-Jean Kim [États-Unis] ; Michael Boeckh ; Janet A. EnglundSource :
- Seminars in respiratory and critical care medicine [ 1069-3424 ] ; 2007.
Descripteurs français
- KwdFr :
- Antiviraux (usage thérapeutique), Humains, Infections communautaires (), Infections communautaires (traitement médicamenteux), Infections de l'appareil respiratoire (), Infections de l'appareil respiratoire (traitement médicamenteux), Infections de l'appareil respiratoire (virologie), Infections opportunistes liées au SIDA (), Infections opportunistes liées au SIDA (immunologie), Infections opportunistes liées au SIDA (traitement médicamenteux), Lutte contre l'infection, Maladies virales (), Maladies virales (traitement médicamenteux), Sujet immunodéprimé, Transplantation d'organe (effets indésirables), Transplantation de cellules souches hématopoïétiques (effets indésirables), Vaccins antiviraux.
- MESH :
- effets indésirables : Transplantation d'organe, Transplantation de cellules souches hématopoïétiques.
- immunologie : Infections opportunistes liées au SIDA.
- traitement médicamenteux : Infections communautaires, Infections de l'appareil respiratoire, Infections opportunistes liées au SIDA, Maladies virales.
- usage thérapeutique : Antiviraux.
- virologie : Infections de l'appareil respiratoire.
- Humains, Infections communautaires, Infections de l'appareil respiratoire, Infections opportunistes liées au SIDA, Lutte contre l'infection, Maladies virales, Sujet immunodéprimé, Vaccins antiviraux.
English descriptors
- KwdEn :
- AIDS-Related Opportunistic Infections (drug therapy), AIDS-Related Opportunistic Infections (immunology), AIDS-Related Opportunistic Infections (prevention & control), Antiviral Agents (therapeutic use), Community-Acquired Infections (drug therapy), Community-Acquired Infections (prevention & control), Hematopoietic Stem Cell Transplantation (adverse effects), Humans, Immunocompromised Host, Infection Control, Organ Transplantation (adverse effects), Respiratory Tract Infections (drug therapy), Respiratory Tract Infections (prevention & control), Respiratory Tract Infections (virology), Viral Vaccines, Virus Diseases (drug therapy), Virus Diseases (prevention & control).
- MESH :
- chemical , therapeutic use : Antiviral Agents.
- adverse effects : Hematopoietic Stem Cell Transplantation, Organ Transplantation.
- drug therapy : AIDS-Related Opportunistic Infections, Community-Acquired Infections, Respiratory Tract Infections, Virus Diseases.
- immunology : AIDS-Related Opportunistic Infections.
- prevention & control : AIDS-Related Opportunistic Infections, Community-Acquired Infections, Respiratory Tract Infections, Virus Diseases.
- virology : Respiratory Tract Infections.
- Humans, Immunocompromised Host, Infection Control, Viral Vaccines.
Abstract
Infection is the leading cause of morbidity and mortality in immunocompromised patients such as hematopoietic/solid organ transplant recipients and individuals with human immunodeficiency virus. Community respiratory virus infections are increasingly recognized as a significant threat to these patients. This article reviews current information in the clinical field of community respiratory viruses, including several newly discovered respiratory viruses. Respiratory syncytial virus, influenza viruses, parainfluenza viruses, and adenoviruses cause the most serious disease in immunocompromised hosts, but other respiratory viruses are becoming increasingly appreciated as a cause of both upper and lower respiratory tract disease. The clinical impact of these new viruses, including human metapneumovirus, non-SARS human coronaviruses, and human bocavirus, is not yet clear. Modern molecular technology has made the discovery of new viruses possible; the use of these new technologies in direct patient care is not yet standard but is becoming increasingly utilized. Clinicians should appreciate the potential for the development of antiviral resistance to influenza antivirals in immunocompromised patients.
DOI: 10.1055/s-2007-976494
PubMed: 17458776
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001E38
- to stream PubMed, to step Curation: 001E38
- to stream PubMed, to step Checkpoint: 001E51
- to stream Ncbi, to step Merge: 001938
- to stream Ncbi, to step Curation: 001938
- to stream Ncbi, to step Checkpoint: 001938
- to stream Main, to step Merge: 003896
- to stream Main, to step Curation: 003749
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.</title><author><name sortKey="Kim, Yae Jean" sort="Kim, Yae Jean" uniqKey="Kim Y" first="Yae-Jean" last="Kim">Yae-Jean Kim</name><affiliation wicri:level="2"><nlm:affiliation>Division of Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington</wicri:regionArea><placeName><region type="state">Washington (État)</region></placeName></affiliation></author><author><name sortKey="Boeckh, Michael" sort="Boeckh, Michael" uniqKey="Boeckh M" first="Michael" last="Boeckh">Michael Boeckh</name></author><author><name sortKey="Englund, Janet A" sort="Englund, Janet A" uniqKey="Englund J" first="Janet A" last="Englund">Janet A. Englund</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17458776</idno><idno type="pmid">17458776</idno><idno type="doi">10.1055/s-2007-976494</idno><idno type="wicri:Area/PubMed/Corpus">001E38</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E38</idno><idno type="wicri:Area/PubMed/Curation">001E38</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001E38</idno><idno type="wicri:Area/PubMed/Checkpoint">001E51</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001E51</idno><idno type="wicri:Area/Ncbi/Merge">001938</idno><idno type="wicri:Area/Ncbi/Curation">001938</idno><idno type="wicri:Area/Ncbi/Checkpoint">001938</idno><idno type="wicri:doubleKey">1069-3424:2007:Kim Y:community:respiratory:virus</idno><idno type="wicri:Area/Main/Merge">003896</idno><idno type="wicri:Area/Main/Curation">003749</idno><idno type="wicri:Area/Main/Exploration">003749</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.</title><author><name sortKey="Kim, Yae Jean" sort="Kim, Yae Jean" uniqKey="Kim Y" first="Yae-Jean" last="Kim">Yae-Jean Kim</name><affiliation wicri:level="2"><nlm:affiliation>Division of Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington</wicri:regionArea><placeName><region type="state">Washington (État)</region></placeName></affiliation></author><author><name sortKey="Boeckh, Michael" sort="Boeckh, Michael" uniqKey="Boeckh M" first="Michael" last="Boeckh">Michael Boeckh</name></author><author><name sortKey="Englund, Janet A" sort="Englund, Janet A" uniqKey="Englund J" first="Janet A" last="Englund">Janet A. Englund</name></author></analytic><series><title level="j">Seminars in respiratory and critical care medicine</title><idno type="ISSN">1069-3424</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS-Related Opportunistic Infections (drug therapy)</term><term>AIDS-Related Opportunistic Infections (immunology)</term><term>AIDS-Related Opportunistic Infections (prevention & control)</term><term>Antiviral Agents (therapeutic use)</term><term>Community-Acquired Infections (drug therapy)</term><term>Community-Acquired Infections (prevention & control)</term><term>Hematopoietic Stem Cell Transplantation (adverse effects)</term><term>Humans</term><term>Immunocompromised Host</term><term>Infection Control</term><term>Organ Transplantation (adverse effects)</term><term>Respiratory Tract Infections (drug therapy)</term><term>Respiratory Tract Infections (prevention & control)</term><term>Respiratory Tract Infections (virology)</term><term>Viral Vaccines</term><term>Virus Diseases (drug therapy)</term><term>Virus Diseases (prevention & control)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (usage thérapeutique)</term><term>Humains</term><term>Infections communautaires ()</term><term>Infections communautaires (traitement médicamenteux)</term><term>Infections de l'appareil respiratoire ()</term><term>Infections de l'appareil respiratoire (traitement médicamenteux)</term><term>Infections de l'appareil respiratoire (virologie)</term><term>Infections opportunistes liées au SIDA ()</term><term>Infections opportunistes liées au SIDA (immunologie)</term><term>Infections opportunistes liées au SIDA (traitement médicamenteux)</term><term>Lutte contre l'infection</term><term>Maladies virales ()</term><term>Maladies virales (traitement médicamenteux)</term><term>Sujet immunodéprimé</term><term>Transplantation d'organe (effets indésirables)</term><term>Transplantation de cellules souches hématopoïétiques (effets indésirables)</term><term>Vaccins antiviraux</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Hematopoietic Stem Cell Transplantation</term><term>Organ Transplantation</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>Community-Acquired Infections</term><term>Respiratory Tract Infections</term><term>Virus Diseases</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Transplantation d'organe</term><term>Transplantation de cellules souches hématopoïétiques</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections opportunistes liées au SIDA</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>Community-Acquired Infections</term><term>Respiratory Tract Infections</term><term>Virus Diseases</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections communautaires</term><term>Infections de l'appareil respiratoire</term><term>Infections opportunistes liées au SIDA</term><term>Maladies virales</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections de l'appareil respiratoire</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Respiratory Tract Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Immunocompromised Host</term><term>Infection Control</term><term>Viral Vaccines</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Infections communautaires</term><term>Infections de l'appareil respiratoire</term><term>Infections opportunistes liées au SIDA</term><term>Lutte contre l'infection</term><term>Maladies virales</term><term>Sujet immunodéprimé</term><term>Vaccins antiviraux</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Infection is the leading cause of morbidity and mortality in immunocompromised patients such as hematopoietic/solid organ transplant recipients and individuals with human immunodeficiency virus. Community respiratory virus infections are increasingly recognized as a significant threat to these patients. This article reviews current information in the clinical field of community respiratory viruses, including several newly discovered respiratory viruses. Respiratory syncytial virus, influenza viruses, parainfluenza viruses, and adenoviruses cause the most serious disease in immunocompromised hosts, but other respiratory viruses are becoming increasingly appreciated as a cause of both upper and lower respiratory tract disease. The clinical impact of these new viruses, including human metapneumovirus, non-SARS human coronaviruses, and human bocavirus, is not yet clear. Modern molecular technology has made the discovery of new viruses possible; the use of these new technologies in direct patient care is not yet standard but is becoming increasingly utilized. Clinicians should appreciate the potential for the development of antiviral resistance to influenza antivirals in immunocompromised patients.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Washington (État)</li></region></list><tree><noCountry><name sortKey="Boeckh, Michael" sort="Boeckh, Michael" uniqKey="Boeckh M" first="Michael" last="Boeckh">Michael Boeckh</name><name sortKey="Englund, Janet A" sort="Englund, Janet A" uniqKey="Englund J" first="Janet A" last="Englund">Janet A. Englund</name></noCountry><country name="États-Unis"><region name="Washington (État)"><name sortKey="Kim, Yae Jean" sort="Kim, Yae Jean" uniqKey="Kim Y" first="Yae-Jean" last="Kim">Yae-Jean Kim</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003749 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003749 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:17458776
|texte= Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:17458776" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |